Steven F. Bronk

Medicine · Health Sciences

67h-index14.6kcitations152works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Liver Disease Diagnosis and Treatment(47), Cholangiocarcinoma and Gallbladder Cancer Studies(40), Cell death mechanisms and regulation(24), Hepatitis B Virus Studies(24), Drug Transport and Resistance Mechanisms(24)

Publications152 total

Supplementary Figure 6 from Therapeutic Effects of Deleting Cancer-Associated Fibroblasts in Cholangiocarcinoma
2023Open Access
Supplementary Figure 6 from Therapeutic Effects of Deleting Cancer-Associated Fibroblasts in Cholangiocarcinoma
2023Open Access
Supplementary Figure 4 from Therapeutic Effects of Deleting Cancer-Associated Fibroblasts in Cholangiocarcinoma
2023Open Access
Supplementary Figure 2 from Therapeutic Effects of Deleting Cancer-Associated Fibroblasts in Cholangiocarcinoma
2023Open Access
Supplementary Methods from Therapeutic Effects of Deleting Cancer-Associated Fibroblasts in Cholangiocarcinoma
2023Open Access
Data from Therapeutic Effects of Deleting Cancer-Associated Fibroblasts in Cholangiocarcinoma
2023Open Access
Supplementary Figure 5 from Therapeutic Effects of Deleting Cancer-Associated Fibroblasts in Cholangiocarcinoma
2023Open Access
Supplementary Figure 4 from Therapeutic Effects of Deleting Cancer-Associated Fibroblasts in Cholangiocarcinoma
2023Open Access
Supplementary Figure 1 from Therapeutic Effects of Deleting Cancer-Associated Fibroblasts in Cholangiocarcinoma
2023Open Access
Supplementary Figure 3 from Therapeutic Effects of Deleting Cancer-Associated Fibroblasts in Cholangiocarcinoma
2023Open Access
Supplementary Figure Legend from Therapeutic Effects of Deleting Cancer-Associated Fibroblasts in Cholangiocarcinoma
2023Open Access
Supplementary Figure 2 from Therapeutic Effects of Deleting Cancer-Associated Fibroblasts in Cholangiocarcinoma
2023Open Access
Data from Therapeutic Effects of Deleting Cancer-Associated Fibroblasts in Cholangiocarcinoma
2023Open Access
Supplementary Figure 3 from Therapeutic Effects of Deleting Cancer-Associated Fibroblasts in Cholangiocarcinoma
2023Open Access
Supplementary Methods from Therapeutic Effects of Deleting Cancer-Associated Fibroblasts in Cholangiocarcinoma
2023Open Access
Supplementary Table 1 from Therapeutic Effects of Deleting Cancer-Associated Fibroblasts in Cholangiocarcinoma
2023Open Access
Supplementary Table 1 from Therapeutic Effects of Deleting Cancer-Associated Fibroblasts in Cholangiocarcinoma
2023Open Access
Supplementary Figure 1 from Therapeutic Effects of Deleting Cancer-Associated Fibroblasts in Cholangiocarcinoma
2023Open Access
Supplementary Figure 5 from Therapeutic Effects of Deleting Cancer-Associated Fibroblasts in Cholangiocarcinoma
2023Open Access
Supplementary Figure Legend from Therapeutic Effects of Deleting Cancer-Associated Fibroblasts in Cholangiocarcinoma
2023Open Access
page 1 of 8Next →

Frequent Co-authors

Gregory J. Gores(43), Nathan W. Werneburg(20), Maria Eugenia Guicciardi(12), Justin L. Mott(10), Hajime Higuchi(8), Sophie C. Cazanave(8), Ali Canbay(7), Ariel E. Feldstein(5), Harmeet Malhi(5), Hideyuki Miyoshi(5), Scott H. Kaufmann(5), Shogo Kobayashi(4), Michael Charlton(4), Nafisa A. Elmi(4), Christian D. Fingas(4), Robert M. Rydzewski(3), Patricia J. Roberts(3), Petra Hirsova(3), Samar H. Ibrahim(3), Vijay H. Shah(3)